NASH phenotype was associated with liver fibrosis, obesity, hyperleptinemia, increased oxidative and ER stress, inflammation, and increased IR and impaired GT (multiple 2nd hits) in WT-fed FF compared to the corresponding Cyp2e1-null mice. The gene discussed is CYP2E1; the disease is metabolic dysfunction-associated steatohepatitis.